Studies presented in this chapter show that: (1) in the brain, ethanol is metabolized by catalase to acetaldehyde, which condenses with dopamine forming salsolinol; (2) acetaldehyde-derived salsolinol increases the release of dopamine mediating, via opioid receptors, the reinforcing effects of ethanol during the acquisition of ethanol consumption, while (3) brain acetaldehyde does not influence the maintenance of chronic ethanol intake, it is suggested that a learned cue-induced hyperglutamatergic system takes precedence over the dopaminergic system. However, (4) following a prolonged ethanol deprivation, the generation of acetaldehyde in the brain again plays a role, contributing to the increase in ethanol intake observed during ethanol re-access, called the alcohol deprivation effect (ADE), a model of relapse behavior; (5) naltrexone inhibits the high ethanol intake seen in the ADE condition, suggesting that acetaldehyde-derived salsolinol via opioid receptors also contributes to the relapse-like drinking behavior. The reader is referred to glutamate-mediated mechanisms that trigger the cue-associated alcohol-seeking and that also contribute to triggering relapse.
Keywords: Acquisition of ethanol intake; Alcohol deprivation effect; Aldehyde dehydrogenase; Aminotriazole; Binge-like drinking; Brain acetaldehyde generation; Brain salsolinol; Catalase; Drug-seeking; Ethanol aversion; Gene therapy; Maintenance of ethanol intake; Naltrexone; Opioid receptor; Penicillamine; Reinforcing effect.
© 2023. The Author(s), under exclusive license to Springer Nature Switzerland AG.